|
ELDN Eledon Pharmaceuticals Inc 1404281 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-39,025,000.00 |
| Balance Sheet |
|
Current Assets
|
$113,574,000.00 |
|
Assets
|
$146,667,000.00 |
|
Current Liabilities
|
$13,458,000.00 |
|
Liabilities
|
$46,209,000.00 |
|
Equity
|
$44,764,000.00 |
|
Shares Out
|
75851722.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-22,612,000.00 |
|
Investing Cash Flow
|
$5,956,000.00 |
| Market Analysis |
Market Cap
|
$258,654,372.02 |
|
Price
|
$3.36 |
|
BVPS
|
0.59 |
|
PB
|
5.78 |
|
EPS
|
-0.33 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:32 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:29 |
|
| Apr |
May |
Jun |
| 2026-03-19 |
-0.52 |
|
|
2026-05-13 |
-0.33 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.13 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-0.21 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ELDN documents filed with the SEC.
ELDN Filings
Clear
